Answers are grounded in this paper and cite their sources.
Clinical trial demonstrates a salivary extracellular vesicle 6-miRNA panel detects and stratifies esophageal squamous cell carcinoma, highlighting a noninvasive screening strategy.
The salivary EVP-based 6-miRNA signature can serve as noninvasive biomarkers for early detection and risk stratification of ESCC. Chinese Clinical Trial Registry, ChiCTR2000031507.
No takes yet. Share an insight, caveat, or question.
Li et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: